Camp4 Therapeutics (CAMP) Current Assets (2023 - 2026)

Camp4 Therapeutics has reported Current Assets for 4 years, with the latest figure at $102.2 million in Q1 2026.

• Quarterly Current Assets rose 97.77% year-over-year to $102.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.2 million (up 97.77% YoY) and the FY2025 annual result came in at $114.1 million, up 71.87% from the prior year.
• Current Assets slipped to $102.2 million in Q1 2026 per CAMP's latest filing, from $114.1 million in the prior quarter.
• Over five years, Current Assets peaked at $114.1 million in Q4 2025 and troughed at $5.5 million in Q3 2024.
• A 4-year average of $62.3 million and a median of $59.0 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets surged 65.9% in 2024, then soared 1311.85% in 2025.
• Over 4 years, Current Assets stood at $40.0 million in 2023, then soared by 65.9% to $66.4 million in 2024, then soared by 71.87% to $114.1 million in 2025, then decreased by 10.43% to $102.2 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $102.2 million, $114.1 million, and $77.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.